SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

PHIA

21.75

-1.27%↓

FME

37.23

+0.92%↑

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

PHIA

21.75

-1.27%↓

FME

37.23

+0.92%↑

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

PHIA

21.75

-1.27%↓

FME

37.23

+0.92%↑

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

PHIA

21.75

-1.27%↓

FME

37.23

+0.92%↑

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

PHIA

21.75

-1.27%↓

FME

37.23

+0.92%↑

Search

Fresenius SE & Co KGaA

Închisă

SectorSănătate

38.8 -0.33

Rezumat

Modificarea prețului

24h

Curent

Minim

38.78

Maxim

39.48

Indicatori cheie

By Trading Economics

Venit

31M

436M

Vânzări

-337M

5.8B

P/E

Medie Sector

14.881

51.415

EPS

0.99

Randament dividend

2.56

Marjă de profit

7.493

Angajați

177,783

EBITDA

58M

902M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+43.39% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.56%

2.34%

Următoarele câștiguri

5 aug. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

248M

22B

Deschiderea anterioară

39.13

Închiderea anterioară

38.8

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Fresenius SE & Co KGaA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 aug. 2025, 10:45 UTC

Market Talk
Câștiguri

Fresenius Beats Subdued Expectations -- Market Talk

Comparație

Modificare preț

Fresenius SE & Co KGaA Așteptări

Obiectiv de preț

By TipRanks

43.39% sus

Prognoză pe 12 luni

Medie 54.96 EUR  43.39%

Maxim 58 EUR

Minim 48 EUR

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFresenius SE & Co KGaA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

42.5 / 43.2Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
help-icon Live chat